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Dependence on Opioids
Derek Luzim, MS-3
University of Vermont College of Medicine




• Chronic pain can be described as ongoing or recurrent pain, lasting beyond the usual 
course of acute illness or injury or more than 3 to 6 months, and which adversely affects the 
individual’s well-being. (ACPA)
• Historically, opioids have been used to treat pain
• Opioids can be helpful in the short-term, but long-term use leads to tolerance, 
dependence, and the risk of diversion and overdose. There is also evidence that opiates 
provide little to no gain in actual functioning and inadequate relief of pain concerns
• Providers and patients need education and support in decreasing opioid use and providing 
alternative modalities for chronic pain treatment
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Public Health Cost
• In the U.S. persistent pain impacts 100 million adults and costs from $560 to 
$635 billion annually.
• Costs include direct medical cost, disability, and lost wages and productivity
• The costs of persistent pain exceed the economic costs of the six most 
costly major diagnoses—cardiovascular diseases ($309 billion); neoplasms 
($243 billion); injury and poisoning ($205 billion); endocrine, nutritional, and 
metabolic diseases ($127 billion); digestive system diseases ($112 billion); 
and respiratory system diseases ($112 billion)
3A
Public Health Cost
• Opioid use, even when medically 
indicated, has its own related public 
health costs




Rodger Kessler, PHD, Berlin Family Practice
• Generation of people addicted to opiates, and they are upset that doctors are now 
decreasing their medications after years of prescribing them for pain. More information will 
not necessarily change their behavior – we have to treat the addiction.
• Berlin Family practice could benefit from better coordination between MDs and 
Community Health Team regarding linkages to community resources.
• The probability of success is low that patients can substantially lower or eliminate their 
dependence on opiates for chronic pain, but success is greater with community-based 
therapy.




Jacqueline M. S. Jancaitis, PT, The RehabGYM, Barre, VT
• Assessment based on functional capacity rather than “how much” pain they feel. Focus 
placed on gaining function that will improve quality of life.
• Ongoing discussion about medications/drugs used, functional improvements appreciated 
during PT, pain experienced, and referral back to doctor for possible medication 
adjustment.
• Mental Health counseling one of the most important ways to assist physical therapy. 
“Occasionally someone is appropriate for yoga or meditation, but mostly it seems coping 
strategies are more appropriate.”
• “Patient's who get off narcotics report to me that they're pain is very different after they 
are off the medication. A lot of them get stuck in a pain cycle on the medication and then 




• Patient information sheet explaining role, limitations, and risks of opioid 
medication for chronic pain
• Provider Information sheet regarding Milligram Morphine Equivalent 
Conversion and evidence about opioid dosage and safety








• Survey was sent to Berlin Family 
Practice Providers for feedback 
and suggestions for 
improvement
• Responses will be reviewed and 
guide changes to intervention 




• Provider survey responses will inform practicality of intervention
• Tracking the number of information sheets given will assess its clinical utility
• Following practice-wide trends will demonstrate progress on this issue. Indicators may 
include the number of patients using opiates for chronic pain and the dosage or Milligram 
Morphine Equivalents prescribed 
• It will be difficult to evaluate role of the information sheet in reducing opiate use vs. 
motivational interviewing and guidance from the provider. 
• Additionally, many other variables will impact patient response such as access to 




• Practice-wide adoption of recommendations from:
Improving Opioid Prescribing: Sustainable Solutions for Vermont. Opioid Prescription 
Management Toolkit for Chronic Pain: Practice Fast Track
Connie van Eeghen, DrPH, Charles D. MacLean, MD, Amanda G. Kennedy, PharmD, BCP
• Provider and Community Health Team meeting(s) to plan specific actions that can increase 
the capacity of the community health team for connecting chronic pain patients with 
community-based resources and services. 
• Continue to educate patients about the risks associated with opioid use and engage in realistic 
goal-setting for functioning with chronic pain 
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